PNC Managed Account Solutions’s Edwards Lifesciences EW Stock Holding History

PNC Managed Account Solutions’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$268K	Buy	+2,587	New	+$244K	0.05%	186

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PNC Managed Account Solutions's EW Position: Q2 2021 in Review

PNC Managed Account Solutions opened a new position in Edwards Lifesciences (EW) in Q2 2021: 2,587 shares worth $268K. The stake represents 0.05% of the portfolio and ranks #186 among its holdings.

1,185 funds tracked by Wall St. Rank hold EW as of Q2 2021.

PNC Managed Account Solutions held 2,587 shares of Edwards Lifesciences worth $268K as of Q2 2021.
Edwards Lifesciences was a new PNC Managed Account Solutions position in Q2 2021.
Edwards Lifesciences made up 0.05% of PNC Managed Account Solutions's portfolio in Q2 2021, its #186 holding.
1,185 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2021.

Based on PNC Managed Account Solutions's 13F filing for Q2 2021, filed 6 Aug 2021.